Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience

Sherry K. Milfred-LaForest, Julie A. Gee, Adam M. Pugacz, Ileana L. Pina, Danielle M. Hoover, Robert C. Wenzell, Aubrey Felton, Eric Guttenberg, Jose Ortiz

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Objective To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. Background Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and symptoms. We hypothesized that combining these elements with optimization of medications would impact outcomes. Methods In the SERIOUS HF Medication Reconciliation Transitional Care Clinic (HF MRTCC), patients were seen by a clinical pharmacist trained in HF. The pharmacist performed medication reconciliation, a basic physical exam, and a HF symptom history. Medications were adjusted by the clinical pharmacist or medical provider. Data were retrospectively collected for a quality improvement evaluation of this novel clinic on medication discrepancies, medications optimized, and 30-day readmissions. Descriptive statistics and paired t-tests were used for medication doses. Results All patients (n = 135) had a diagnosis of HF, 59% were recently discharged. The mean time from discharge to the clinic appointment was 10 ± 6 days, and the 30 day all-cause readmission rate was 9%. Medication discrepancies were detected in 53% of patients. Medications were optimized in 70%, most frequently beta blockers, ace inhibitors, and diuretics. In patients with an ejection fraction ≤ 40%, significantly higher doses of beta blockers and ace inhibitors were prescribed after the clinic visit. Conclusion The HF MRTCC identified and corrected numerous medication discrepancies, up-titrated medications, and was associated with a 30-day readmission rate of 9%. These encouraging pilot results are hypothesis-generating and warrant further controlled trials.

Original languageEnglish (US)
Pages (from-to)249-258
Number of pages10
JournalProgress in Cardiovascular Diseases
Volume60
Issue number2
DOIs
StatePublished - Sep 1 2017

Fingerprint

Patient Transfer
Pharmacists
Heart Failure
Medication Reconciliation
Ambulatory Care
Quality Improvement
Diuretics
Signs and Symptoms
Appointments and Schedules
History

Keywords

  • Heart failure
  • Medication reconciliation
  • Transition

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Milfred-LaForest, S. K., Gee, J. A., Pugacz, A. M., Pina, I. L., Hoover, D. M., Wenzell, R. C., ... Ortiz, J. (2017). Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience. Progress in Cardiovascular Diseases, 60(2), 249-258. https://doi.org/10.1016/j.pcad.2017.08.005

Heart Failure Transitions of Care : A Pharmacist-Led Post-Discharge Pilot Experience. / Milfred-LaForest, Sherry K.; Gee, Julie A.; Pugacz, Adam M.; Pina, Ileana L.; Hoover, Danielle M.; Wenzell, Robert C.; Felton, Aubrey; Guttenberg, Eric; Ortiz, Jose.

In: Progress in Cardiovascular Diseases, Vol. 60, No. 2, 01.09.2017, p. 249-258.

Research output: Contribution to journalReview article

Milfred-LaForest, SK, Gee, JA, Pugacz, AM, Pina, IL, Hoover, DM, Wenzell, RC, Felton, A, Guttenberg, E & Ortiz, J 2017, 'Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience', Progress in Cardiovascular Diseases, vol. 60, no. 2, pp. 249-258. https://doi.org/10.1016/j.pcad.2017.08.005
Milfred-LaForest SK, Gee JA, Pugacz AM, Pina IL, Hoover DM, Wenzell RC et al. Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience. Progress in Cardiovascular Diseases. 2017 Sep 1;60(2):249-258. https://doi.org/10.1016/j.pcad.2017.08.005
Milfred-LaForest, Sherry K. ; Gee, Julie A. ; Pugacz, Adam M. ; Pina, Ileana L. ; Hoover, Danielle M. ; Wenzell, Robert C. ; Felton, Aubrey ; Guttenberg, Eric ; Ortiz, Jose. / Heart Failure Transitions of Care : A Pharmacist-Led Post-Discharge Pilot Experience. In: Progress in Cardiovascular Diseases. 2017 ; Vol. 60, No. 2. pp. 249-258.
@article{be9f1eabf93f41dbbd6241954a310512,
title = "Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience",
abstract = "Objective To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. Background Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and symptoms. We hypothesized that combining these elements with optimization of medications would impact outcomes. Methods In the SERIOUS HF Medication Reconciliation Transitional Care Clinic (HF MRTCC), patients were seen by a clinical pharmacist trained in HF. The pharmacist performed medication reconciliation, a basic physical exam, and a HF symptom history. Medications were adjusted by the clinical pharmacist or medical provider. Data were retrospectively collected for a quality improvement evaluation of this novel clinic on medication discrepancies, medications optimized, and 30-day readmissions. Descriptive statistics and paired t-tests were used for medication doses. Results All patients (n = 135) had a diagnosis of HF, 59{\%} were recently discharged. The mean time from discharge to the clinic appointment was 10 ± 6 days, and the 30 day all-cause readmission rate was 9{\%}. Medication discrepancies were detected in 53{\%} of patients. Medications were optimized in 70{\%}, most frequently beta blockers, ace inhibitors, and diuretics. In patients with an ejection fraction ≤ 40{\%}, significantly higher doses of beta blockers and ace inhibitors were prescribed after the clinic visit. Conclusion The HF MRTCC identified and corrected numerous medication discrepancies, up-titrated medications, and was associated with a 30-day readmission rate of 9{\%}. These encouraging pilot results are hypothesis-generating and warrant further controlled trials.",
keywords = "Heart failure, Medication reconciliation, Transition",
author = "Milfred-LaForest, {Sherry K.} and Gee, {Julie A.} and Pugacz, {Adam M.} and Pina, {Ileana L.} and Hoover, {Danielle M.} and Wenzell, {Robert C.} and Aubrey Felton and Eric Guttenberg and Jose Ortiz",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.pcad.2017.08.005",
language = "English (US)",
volume = "60",
pages = "249--258",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Heart Failure Transitions of Care

T2 - A Pharmacist-Led Post-Discharge Pilot Experience

AU - Milfred-LaForest, Sherry K.

AU - Gee, Julie A.

AU - Pugacz, Adam M.

AU - Pina, Ileana L.

AU - Hoover, Danielle M.

AU - Wenzell, Robert C.

AU - Felton, Aubrey

AU - Guttenberg, Eric

AU - Ortiz, Jose

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Objective To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. Background Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and symptoms. We hypothesized that combining these elements with optimization of medications would impact outcomes. Methods In the SERIOUS HF Medication Reconciliation Transitional Care Clinic (HF MRTCC), patients were seen by a clinical pharmacist trained in HF. The pharmacist performed medication reconciliation, a basic physical exam, and a HF symptom history. Medications were adjusted by the clinical pharmacist or medical provider. Data were retrospectively collected for a quality improvement evaluation of this novel clinic on medication discrepancies, medications optimized, and 30-day readmissions. Descriptive statistics and paired t-tests were used for medication doses. Results All patients (n = 135) had a diagnosis of HF, 59% were recently discharged. The mean time from discharge to the clinic appointment was 10 ± 6 days, and the 30 day all-cause readmission rate was 9%. Medication discrepancies were detected in 53% of patients. Medications were optimized in 70%, most frequently beta blockers, ace inhibitors, and diuretics. In patients with an ejection fraction ≤ 40%, significantly higher doses of beta blockers and ace inhibitors were prescribed after the clinic visit. Conclusion The HF MRTCC identified and corrected numerous medication discrepancies, up-titrated medications, and was associated with a 30-day readmission rate of 9%. These encouraging pilot results are hypothesis-generating and warrant further controlled trials.

AB - Objective To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. Background Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and symptoms. We hypothesized that combining these elements with optimization of medications would impact outcomes. Methods In the SERIOUS HF Medication Reconciliation Transitional Care Clinic (HF MRTCC), patients were seen by a clinical pharmacist trained in HF. The pharmacist performed medication reconciliation, a basic physical exam, and a HF symptom history. Medications were adjusted by the clinical pharmacist or medical provider. Data were retrospectively collected for a quality improvement evaluation of this novel clinic on medication discrepancies, medications optimized, and 30-day readmissions. Descriptive statistics and paired t-tests were used for medication doses. Results All patients (n = 135) had a diagnosis of HF, 59% were recently discharged. The mean time from discharge to the clinic appointment was 10 ± 6 days, and the 30 day all-cause readmission rate was 9%. Medication discrepancies were detected in 53% of patients. Medications were optimized in 70%, most frequently beta blockers, ace inhibitors, and diuretics. In patients with an ejection fraction ≤ 40%, significantly higher doses of beta blockers and ace inhibitors were prescribed after the clinic visit. Conclusion The HF MRTCC identified and corrected numerous medication discrepancies, up-titrated medications, and was associated with a 30-day readmission rate of 9%. These encouraging pilot results are hypothesis-generating and warrant further controlled trials.

KW - Heart failure

KW - Medication reconciliation

KW - Transition

UR - http://www.scopus.com/inward/record.url?scp=85031748779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031748779&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2017.08.005

DO - 10.1016/j.pcad.2017.08.005

M3 - Review article

C2 - 28826670

AN - SCOPUS:85031748779

VL - 60

SP - 249

EP - 258

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 2

ER -